Description

18F Fluorodeoxyglucose (18F-FDG) is a positron-emitting radiopharmaceutical essential for non-invasive metabolic imaging in modern medicine. Its core value lies in its ability to act as a glucose analog, allowing for the visualization and quantification of glucose metabolism in tissues using Positron Emission Tomography (PET). This product is critically needed by radiopharmacies, nuclear medicine departments, and clinical research organizations for diagnostic oncology, neurology, and cardiology.

Application

• Oncology (Cancer Diagnostics): Primary application for detecting, staging, and monitoring the metabolic activity of malignant tumors, including lung, breast, and colorectal cancers.
• Neurology & Psychiatry: Used in brain imaging to localize epileptic foci, diagnose dementia (e.g., Alzheimer's disease), and study brain metabolism in various psychiatric disorders.
• Cardiology: Assessment of myocardial viability in patients with coronary artery disease to distinguish between hibernating and infarcted heart tissue.
• Infectious Disease & Inflammation: Detection and localization of sites of infection or inflammation, such as fever of unknown origin or sarcoidosis.
• Clinical Research: A vital tool in pharmaceutical development for evaluating drug efficacy and disease progression in clinical trials.
• Radiopharmaceutical Synthesis: Serves as the active pharmaceutical ingredient (API) for the aseptic preparation of unit doses in licensed radiopharmacies.

Basic Information

Product Name	18F Fluorodeoxyglucose
CAS No.	63503-12-8
Molecular Formula	C6H11FO5
Molecular Weight	182.15 g/mol
Synonyms	18F-FDG; Fluorodeoxyglucose F 18; Fludeoxyglucose (18F); 2-Deoxy-2-[18F]fluoro-D-glucose; FDG-18; [18F]FDG; FDG; Fludeoxyglucose F18; Fludeoxyglucose (18F) Injection
EINECS	Contact for details

Quality Control

Our 18F Fluorodeoxyglucose is manufactured under strict quality systems suitable for radiopharmaceutical applications. Each batch is tested to ensure it meets critical parameters for radiochemical purity, chemical purity, and sterility. Certificates of Analysis (COA) are provided, detailing results for radionuclidic identity, pH, bacterial endotoxins, and sterility in compliance with major pharmacopoeial guidelines. We support compliance with cGMP, USP <823>, and EP standards.

Storage

Preserve in a tightly closed container, protected from light. Due to the radioactive nature of the product, it must be stored and handled in accordance with local radiation safety regulations. The product is typically supplied in a single-dose vial and should be used promptly after receipt due to the short half-life of Fluorine-18 (~110 minutes). Store at controlled room temperature or as specified on the vial label.

Specification

Item	Specification
Appearance	Clear, colorless solution
Identification (HPLC/TLC)	Conforms to standard
Radiochemical Purity (HPLC)	≥ 95%
Chemical Purity	Meets established limits
Specific Activity	Contact for details
pH	4.5 - 7.5
Radionuclidic Identity (Half-life)	105 - 115 minutes
Bacterial Endotoxins	< 175 EU/Vial
Sterility	Sterile

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.